New Delhi, February 21 Union Health Minister J P Nadda launched the indigenously manufactured tetanus and adult diphtheria (Td) vaccine at the Central Research Institute in Kasauli, Himachal Pradesh, on Saturday.With the formal launch of the Td vaccine, it is now being supplied under the...
antenatal check-ups
central research institute kasauli
child immunization
covid-19 vaccination
disease prevention
good manufacturing practices
immunization
india
public health infrastructure
tetanus diphtheria vaccine
u-win
universal immunization program
vaccine development
vaccine maitri
vaccinemanufacturing
Kasauli, February 21 – Union Minister for Health and Family Welfare J. P. Nadda launched the indigenously manufactured tetanus and adult diphtheria (Td) vaccine at the Central Research Institute (CRI) here in Himachal Pradesh on Saturday.Addressing the gathering, Union Minister Nadda...
adult diphtheria vaccine
antenatal check-ups
central research institute (cri)
covid-19 vaccination
good manufacturing practices (gmp)
health and family welfare
himachal pradesh
immunization
india
j. p. nadda
tetanus vaccine
u-win
universal immunization programme (uip)
vaccine maitri
vaccinemanufacturing
New Delhi, February 21 – Union Health Minister JP Nadda launched the locally manufactured Tetanus and Adult Diphtheria (Td) vaccine at the Central Research Institute in Himachal Pradesh on Saturday, calling it a historic step towards strengthening India’s public health system and achieving...
adult diphtheria vaccine
central research institute kasauli
covid-19 vaccines
healthcare
himachal pradesh
india
public health
regulatory systems
td vaccine
tetanus vaccine
universal immunization programme
vaccine development
vaccine maitri
vaccinemanufacturing
who benchmarking
Hyderabad, February 12 Biological E Limited announced on Thursday that the WHO has granted phase II pre-qualification for its Novel Oral Polio Vaccine type 2.Phase II pre-qualification covers both the drug substance and the drug product manufactured at BE, completing the full manufacturing...
biological e limited
circulating vaccine-derived poliovirus type 2 (cvdpv2)
novel oral polio vaccine type 2
polio vaccinevaccinemanufacturing
who pre-qualification